C. Patrick Reynolds

28.9k citations

338 papers · 21.8k indexed · 7 hit papers · h-index 74

Impact in

Neurology top 0.02%
- Neuroblastoma Research and Treatments
Cancer Research top 0.1%
- Cancer, Hypoxia, and Metabolism

Papers in

Neurology 191
- Neuroblastoma Research and Treatments 189
Cancer Research 71
- Cancer, Hypoxia, and Metabolism 58

Co-authors: Mary M. Tomayko Robert C. Seeger Min H. Kang Katherine K. Matthay John M. Maris Judith G. Villablanca Malcolm A. Smith Hiroyuki Shimada
Journals: Pediatric Blood & Cancer (69 papers)Journal of Clinical Oncology (33 papers)Cancer Research (23 papers)Clinical Cancer Research (13 papers)Molecular Cancer Therapeutics (12 papers)
Partner nations: United States Australia Canada

In The Last Decade

C. Patrick Reynolds

333 papers receiving 21.4k citations

Hit Papers

7 papers align trajectories log scale

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma 2010 · 1.2k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2010 New England Journal of Medicine
2009 Clinical Cancer Research
2009 Journal of Clinical Oncology
1999 New England Journal of Medicine
1991 Proceedings of the National Academy of Sciences
1989 Cancer Chemotherapy and Pharmacology
1985 Nature

Peers

Countries citing papers authored by C. Patrick Reynolds

Since Specialization

Citations

This map shows the geographic impact of C. Patrick Reynolds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Patrick Reynolds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Patrick Reynolds more than expected).

Fields of papers citing papers by C. Patrick Reynolds

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Patrick Reynolds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Patrick Reynolds. The network helps show where C. Patrick Reynolds may publish in the future.

Co-authors

The 25 scholars most cited alongside C. Patrick Reynolds, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Patrick Reynolds Line = papers co-authored together C. Patrick Reynolds links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Fenretinide via NOXA Induction, Enhanced Activity of the BCL-2 Inhibitor Venetoclax in High BCL-2–Expressing Neuroblastoma Preclinical Models Molecular Cancer Therapeutics ·Thinh H. Nguyen, Yayuk Ike, Sung‐Jen Wei, White Jm, Monish Ram Makena, Eduardo Urias, Min H. Kang, C. Patrick Reynolds	2019	17
2	Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy SHILAP Revista de lepidopterología ·Mark A. Osborne, C. Patrick Reynolds	2018	3
3	Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: A California Cancer Consortium Trial Clinical Cancer Research ·Ann Mohrbacher, Allen S. Yang, Susan Groshen, Shivaani Kummar, Martin Gutierrez, Min H. Kang, Denice Tsao‐Wei, C. Patrick Reynolds, Edward M. Newman, Barry J. Maurer	2017	28
4	Reactive Oxygen Species–Mediated Synergism of Fenretinide and Romidepsin in Preclinical Models of T-cell Lymphoid Malignancies Molecular Cancer Therapeutics ·Monish Ram Makena, Yayuk Ike, Thinh H. Nguyen, Min H. Kang, C. Patrick Reynolds	2017	29
5	Reactive Oxygen Species Mediates the Synergistic Activity of Fenretinide Combined with the Microtubule Inhibitor ABT-751 against Multidrug-Resistant Recurrent Neuroblastoma Xenografts Molecular Cancer Therapeutics ·J. Brent Myers, Manuel Vega Reyna, Vazgen Khankaldyyan, Hiroyuki Shimada, Michael M. Song, Barry J. Maurer, C. Patrick Reynolds	2016	19
6	Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse Analysis Cancer Research ·Brendan Murphy, Παναγιώτης Γαρίνης, John M. Maris, E. Anders Kolb, Richard Görlick, C. Patrick Reynolds, Min H. Kang, Stephen T. Keir, Raushan T. Kurmasheva, Igor Dvorchik, Jianrong Wu, Catherine A. Billups, Giuseppe Trocino, Malcolm A. Smith, Richard B. Lock, Peter J. Houghton	2016	40
7	Modulation of Glucocorticoid Resistance in Pediatric T-cell Acute Lymphoblastic Leukemia by Increasing BIM Expression with the PI3K/mTOR Inhibitor BEZ235 Clinical Cancer Research ·豊和春日, C. Patrick Reynolds, Min H. Kang	2015	71
8	Activity of MM-398, Nanoliposomal Irinotecan (nal-IRI), in Ewing's Family Tumor Xenografts Is Associated with High Exposure of Tumor to Drug and High SLFN11 Expression Clinical Cancer Research ·Min H. Kang, Jing Wang, Monish Ram Makena, Henri D'Halluin, Nancy Paz, 豊和春日, Michael M. Song, Ruben I. Calderon, M. S. Kim, Ashly Hindle, Y Zhang, Jonathan B. Fitzgerald, Daryl C. Drummond, Timothy J. Triche, C. Patrick Reynolds	2015	85
9	Crizotinib Synergizes with Chemotherapy in Preclinical Models of Neuroblastoma Clinical Cancer Research ·Kateryna Krytska, Hannah T. Ryles, Renata Sano, Pichai Raman, Nicole R. Infarinato, Maslen, Monish Ram Makena, Michael M. Song, C. Patrick Reynolds, Yaël P. Mossé	2015	76
10	Synergistic Activity of PARP Inhibition by Talazoparib (BMN 673) with Temozolomide in Pediatric Cancer Models in the Pediatric Preclinical Testing Program Clinical Cancer Research ·Malcolm A. Smith, C. Patrick Reynolds, Min H. Kang, E. Anders Kolb, Richard Görlick, Hernán Carol, Richard B. Lock, Stephen T. Keir, John M. Maris, Catherine A. Billups, Dmitry Lyalin, Raushan T. Kurmasheva, Peter J. Houghton	2014	90
11	Mitochondrial Bcl-2 Family Dynamics Define Therapy Response and Resistance in Neuroblastoma Cancer Research ·Kelly C. Goldsmith, Shengchuan He, Katsuo Yamashita, Hesti Kusumangingrum, Xueyuan Liu, Annette Vu, 阮卫泓, Rong Guo, Huaqing Zhao, C. Patrick Reynolds, Michael D. Hogarty	2012	62
12	Synergistic Activity of Fenretinide and the Bcl-2 Family Protein Inhibitor ABT-737 against Human Neuroblastoma Clinical Cancer Research ·Hua Fang, A Schmidt, Ondrej Kalous, Burckhardt Helferich, Yves A. DeClerck, C. Patrick Reynolds	2011	31
13	Stage 2 Combination Testing of Rapamycin with Cytotoxic Agents by the Pediatric Preclinical Testing Program Molecular Cancer Therapeutics ·Peter J. Houghton, Christopher L. Morton, Richard Görlick, Richard B. Lock, Hernán Carol, C. Patrick Reynolds, Min H. Kang, John M. Maris, Stephen T. Keir, E. Anders Kolb, 蓝光临, Amy Wozniak, Catherine A. Billups, Larry Rubinstein, Malcolm A. Smith	2010	79
14	Inhibition of the Insulin-Like Growth Factor I Receptor by Epigallocatechin Gallate Blocks Proliferation and Induces the Death of Ewing Tumor Cells Molecular Cancer Therapeutics ·Hyung‐Gyoo Kang, Çağrı Talay, Xian Fang Liu, C. Patrick Reynolds, Timothy J. Triche, Poul H. Sorensen	2010	38
15	Comparison of Primary Neuroblastoma Tumors and Derivative Early-Passage Cell Lines Using Genome-Wide Single Nucleotide Polymorphism Array Analysis Cancer Research ·Samuel L. Volchenboum, Cheng Li, Shuli Li, Edward F. Attiyeh, C. Patrick Reynolds, John M. Maris, A. Thomas Look, Rani E. George	2009	21
16	Molecular Characterization of the Pediatric Preclinical Testing Panel Clinical Cancer Research ·Geoffrey Neale, Xiaoping Su, Christopher L. Morton, Doris A. Phelps, Richard Görlick, Richard B. Lock, C. Patrick Reynolds, John M. Maris, Henry S. Friedman, Jeffrey S. Dome, Joseph D. Khoury, Timothy J. Triche, Robert C. Seeger, Richard J. Gilbertson, Javed Khan, Malcolm A. Smith, Peter J. Houghton	2008	95
17	Sodium Thiosulfate Administered Six Hours after Cisplatin Does Not Compromise Antineuroblastoma Activity Clinical Cancer Research ·A Schmidt, Ondrej Kalous, Alexander Neuwelt, Yuan-Xie Ming, Lingyun Ji, Peter M. Iovine, Richard Sposto, Edward A. Neuwelt, C. Patrick Reynolds	2008	50
18	The Activity of Zoledronic Acid on Neuroblastoma Bone Metastasis Involves Inhibition of Osteoclasts and Tumor Cell Survival and Proliferation Cancer Research ·Hongjun Peng, Yasuyoshi Sohara, Rex Moats, Marvin D. Nelson, Susan Groshen, Wei Ye, C. Patrick Reynolds, Yves A. DeClerck	2007	41
19	Credentialing Preclinical Pediatric Xenograft Models Using Gene Expression and Tissue Microarray Analysis Cancer Research ·Craig C. Whiteford, Sven Bilke, Braden T. Greer, Qingrong Chen, Till Braunschweig, Totonchi Mohammad ziae, Jun S. Wei, Malcolm A. Smith, Peter J. Houghton, Christopher L. Morton, C. Patrick Reynolds, Richard B. Lock, Richard Görlick, Chand Khanna, Carol J. Thiele, Mikiko Takikita, Daniel Catchpoole, Stephen M. Hewitt, Javed Khan	2007	91
20	E-Cadherin Cell-Cell Adhesion in Ewing Tumor Cells Mediates Suppression of Anoikis through Activation of the ErbB4 Tyrosine Kinase Cancer Research ·Hyung‐Gyoo Kang, Çağrı Talay, Cahya Maulidya, Nino Keshelava, Hiroyuki Shimada, William A. May, Tony Ng, C. Patrick Reynolds, Timothy J. Triche, Poul H. Sorensen	2007	146

About C. Patrick Reynolds

C. Patrick Reynolds is a scholar working on Neurology, Cancer Research, Molecular Biology, Oncology and Genetics, having authored 338 papers that have together received 21.8k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (189 papers), Cancer therapeutics and mechanisms (77 papers), Cancer, Hypoxia, and Metabolism (58 papers), Retinoids in leukemia and cellular processes (48 papers), Cell death mechanisms and regulation (24 papers), Virus-based gene therapy research (19 papers), Protein Degradation and Inhibitors (19 papers) and Glioma Diagnosis and Treatment (17 papers). The work is most often cited by research in Neurology (9.7k citations), Cancer Research (4.8k citations), Molecular Biology (12.7k citations), Oncology (5.0k citations) and Genetics (1.4k citations). C. Patrick Reynolds has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Mary M. Tomayko, Robert C. Seeger, Min H. Kang, Katherine K. Matthay, John M. Maris, Judith G. Villablanca, Malcolm A. Smith, Hiroyuki Shimada, Barry J. Maurer and Peter J. Houghton. Their work appears in journals such as Pediatric Blood & Cancer, Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact